Who are GTU-multHIV B vaccine and LIPO-5 vaccine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Comirnaty, Prevnar 20, EV71 inactived vaccine（Vero cells）, MMR followed by YF, IPV at 14 and 22 weeks of age, Rotarix, mRNA-1283.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/gtu-multhiv-b-vaccine-and-lipo-5-vaccine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

GTU-multHIV B vaccine and LIPO-5 vaccine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

GTU-multHIV B vaccine and LIPO-5 vaccine (GTU-multHIV B vaccine and LIPO-5 vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: vaccine. Area: Infectious Disease.

phase 2 vaccine Multiple HIV epitopes Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

GTU-multHIV B vaccine and LIPO-5 vaccine (GTU-multHIV B vaccine and LIPO-5 vaccine) — ANRS, Emerging Infectious Diseases. The GTU-multHIV B vaccine and LIPO-5 vaccine target multiple HIV epitopes to stimulate both humoral and cellular immune responses.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
GTU-multHIV B vaccine and LIPO-5 vaccine TARGET	GTU-multHIV B vaccine and LIPO-5 vaccine	ANRS, Emerging Infectious Diseases	phase 2	vaccine	Multiple HIV epitopes
Comirnaty	BNT162b2 (tozinameran)	Pfizer Inc.	marketed	vaccine	SARS-CoV-2 virus	2021-08-23
Prevnar 20	pneumococcal 20-valent conjugate vaccine (PCV20)	Pfizer Inc.	marketed	Pneumococcal conjugate vaccine	Streptococcus pneumoniae capsular polysaccharides (20 serotypes)	2021-06-08
EV71 inactived vaccine（Vero cells）	EV71 inactived vaccine（Vero cells）	Sinovac Biotech Co., Ltd	marketed	inactivated viral vaccine	Enterovirus 71 (EV71) viral antigens
MMR followed by YF	MMR followed by YF	Alba Maria Ropero	marketed	Live attenuated viral vaccine combination
IPV at 14 and 22 weeks of age, Rotarix	IPV at 14 and 22 weeks of age, Rotarix	Centers for Disease Control and Prevention	marketed	vaccine
mRNA-1283	mRNA-1283	ModernaTX, Inc.	marketed	mRNA vaccine	HPV16 and HPV18 antigens (E6 and E7 proteins)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2033-06-01 — Prevnar 20 · US 8,895,024 · Composition of matter · US
2035-06-01 — Prevnar 20 · US 10,279,033 · Method of use · US

Sponsor landscape (vaccine class)

Pfizer · 20 drugs in this class
Sanofi Pasteur, a Sanofi Company · 20 drugs in this class
GlaxoSmithKline · 12 drugs in this class
Merck Sharp & Dohme LLC · 12 drugs in this class
Centers for Disease Control and Prevention · 9 drugs in this class
Zhejiang Provincial Center for Disease Control and Prevention · 7 drugs in this class
Jiangsu Province Centers for Disease Control and Prevention · 6 drugs in this class
Beijing Center for Disease Control and Prevention · 6 drugs in this class
International Centre for Diarrhoeal Disease Research, Bangladesh · 5 drugs in this class
Sinovac Biotech Co., Ltd · 4 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). GTU-multHIV B vaccine and LIPO-5 vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/gtu-multhiv-b-vaccine-and-lipo-5-vaccine. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab